Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novopharm states intention to market generic ranitidine

Aug. 16, 1996

Glaxo Wellcome fights Novopharm attempt to market generic ranitidine

Aug. 16, 1996

Canadian researchers report GLP-2's potential as digestive disease treatment

Aug. 9, 1996

Astra reports gastrin secretion inhibitors

Aug. 9, 1996

CL-316243: Claimed as gastrointestinal disorders treatment by Glaxo Wellcome

July 26, 1996

Anti-H. pylori compound from Toyama

July 26, 1996

Thiophene and thiophene derivatives described by Sankyo as ulcer treatment

July 26, 1996

Anti-H. pylori cephem compounds described by Fujisawa

July 26, 1996

Alferon N injection undergoes phase III in HCV

July 19, 1996

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...